Purple Biotech Ltd. (PPBT) stock
PPBTNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.56+0.07 (+4.70%)
Close on Nov 12, 2026Market cap $1.45MP/E 0.0Yield –
Purple Biotech cash
Cash and short-term investments held at the end of each period.
Purple Biotech's cash was $8.72M at Dec 31, 2025. For fiscal 2025 it was $8.72M, up 17.8% from the year before. Over ten years it grew -1.9% a year on average. The highest annual figure on record is $15.03M in fiscal 2022.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $8.72M | +17.8% |
| FY2024 | Dec 31, 2024 | $7.40M | -48.9% |
| FY2023 | Dec 31, 2023 | $14.49M | -3.6% |
| FY2022 | Dec 31, 2022 | $15.03M | +38.0% |
| FY2021 | Dec 31, 2021 | $10.89M | -3.2% |
| FY2020 | Dec 31, 2020 | $11.25M | +156.5% |
| FY2019 | Dec 31, 2019 | $4.39M | -15.1% |
| FY2018 | Dec 31, 2018 | $5.16M | +30.8% |
| FY2017 | Dec 31, 2017 | $3.95M | -41.6% |
| FY2016 | Dec 31, 2016 | $6.76M | -36.0% |
| FY2015 | Dec 31, 2015 | $10.56M | +704.1% |
| FY2014 | Dec 31, 2014 | $1.31M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2025 | Dec 31, 2025 | $8.72M | -20.0% |
| Q4 FY2024 | Dec 31, 2024 | $7.40M | -34.2% |
| Q4 FY2023 | Dec 31, 2023 | $14.49M | +230.4% |
| Q4 FY2022 | Dec 31, 2022 | $15.03M | +445.2% |
| Q4 FY2021 | Dec 31, 2021 | $10.89M | +110.9% |
| Q4 FY2020 | Dec 31, 2020 | $11.25M | +109.7% |
| Q4 FY2019 | Dec 31, 2019 | $4.39M | +11.1% |
| Q2 FY2019 | Jun 30, 2019 | $2.76M | +423.1% |
| Q4 FY2018 | Dec 31, 2018 | $5.16M | -23.6% |
| Q2 FY2018 | Jun 30, 2018 | $5.36M | -49.2% |
| Q4 FY2017 | Dec 31, 2017 | $3.95M | +200.6% |
| Q2 FY2017 | Jun 30, 2017 | $527.00K | – |
| Q4 FY2016 | Dec 31, 2016 | $6.76M | – |
| Q4 FY2015 | Dec 31, 2015 | $10.56M | – |
| Q4 FY2014 | Dec 31, 2014 | $1.31M | – |
See a number that looks wrong?